Navigation Links
Listing Review initiated by the Toronto Stock Exchange
Date:11/3/2008

TORONTO, Nov. 3 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: PMD; PREMF.pk) today announced it has been notified by the Toronto Stock Exchange ("TSX") that it is reviewing the eligibility of the Company's common shares for continued listing on the TSX.

The Company is being reviewed under the TSX's Remedial Review Process and has been granted 210 days to comply with all requirements for continued listing. If the Company cannot demonstrate that it meets all TSX listing requirements on or before June 2, 2009, the Company's common shares will be delisted 30 days from such date. A meeting of the TSX's Listings Committee is scheduled to be held on May 28, 2009 to consider whether to delist the common shares of the Company. The TSX has also advised that, if the TSX becomes aware of additional negative developments such that the continued trading or listing of the Company's shares is contrary to the public interest, an expedited listing review could be initiated.

Over the next months, while the Company awaits their FDA appeal decision and other corporate developments, PreMD will evaluate its options in dealing with the TSX and will provide updates as they become available.

About PreMD Inc.

PreMD Inc. is a leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. PreMD's cardiovascular products include PREVU* POC and PREVU* LT, both non-invasive skin cholesterol tests. The Company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. PreMD's head office is located in Toronto, Ontario and its research and product development facility is at McMaster University in Hamilton, Ontario. For more information about PreMD, please visit http://www.premdinc.com.

This press release contains forward-looking statements. These statements involve known and unknown risks a
'/>"/>

SOURCE PreMD Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Standard Management Announces OTCBB Listing
2. Pharsight Files Application for Nasdaq Capital Market Listing
3. InfoLogix Announces Approval for NASDAQ Listing
4. AKELA Pharma Inc. announces U.S. public offering and proposed listing
5. XTL Announces Delisting From the Official List of the United Kingdom Listing Authority
6. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
7. Cash Technologies Discusses AMEX Listing Requirements
8. MedQuist Files Preliminary Proxy Statement and Applies for Listing on NASDAQ
9. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
10. HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ
11. Elbit Imaging Ltd. Selected for Listing on Nasdaq Global Select Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Angeles, CA (PRWEB) March 06, 2015 Los ... offering a special promotion for Zoom whitening. Zoom is a ... in a professional setting. Unlike other teeth whitening treatments, Zoom ... bright and free of stains. For a limited time, Dr. ... significant discount from the usual price of $650 and allows ...
(Date:3/6/2015)... Dr. Mark Sowell recently returned from leading a three day ... advanced education in the field of dentistry, Spear Education draws ... visiting faculty member of this prestigious institution, Dr. Sowell is ... Spear Education to participate in a specialized workshop. Of the ... the top 10% and those willing to sacrifice to be ...
(Date:3/6/2015)... 06, 2015 Medical Products, Inc., a ... agreement with GE Healthcare to become an authorized distributor ... States. , MPI has 31 years in distribution within ... , With this agreement, MPI will have the opportunity ... healthcare industry. , MPI has always strived to ...
(Date:3/6/2015)... The Public Health Accreditation Board (PHAB) ... seven more health departments. This week’s decisions by PHAB’s ... now be assured that their health departments demonstrate the ... communities. , Public health departments play a critical role ... communities. Across the nation, health departments provide a range ...
(Date:3/5/2015)... (PRWEB) March 06, 2015 In 2014, ... being first–in-class. AstraZeneca tops the list scoring 4 drug ... over 25% of all FDA approved drug products, followed ... mechanisms such as anti-PCSK9, anti-PD1 and CDK inhibitors keep ... approved by the FDA to treat metastatic melanoma, and ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3
... the consumption of fizzy soft drinks, according to a new ... have revealed that drinking the equivalent //of two cans of ... combat dementia in older people. ,Psychology lecturer ... for exams could benefit from increasing the amount of sugar ...
... Professor Susana Martinez-conde and her research team from Barrow Neurological ... movements occurring inside the eye even when the person ... proper visibility. ,Even when we are gazing at ... things visible and if these movement stops it leads to ...
... the country in question, Turkey has pointed out that its ... ,They say that those countries are hiding outbreaks of ... killed four Turkish children. ,In the words of the ... illness exists in our neighbouring countries which are ruled by ...
... for understanding the mechanism of joint motion and movement of ... as these are the regions which are mostly being used ... University of Florida is developing a robot which accurately detects ... they are working or walking. ,By understanding how ...
... Researchers at the University of North Carolina (UNC) at Chapel ... the lungs of patients affected by cystic fibrosis (CF). Hypertonic ... of the salt. ,The researchers arrived at this ... two weeks., They found that inhaling the salt solution improved ...
... marketing a single treatment malarial drug, by the World ... may develop a resistance to it. // ... that the practice of using artemisinin, one of the ... the parasite becoming resistant to the drug, and will ...
Cached Medicine News:
(Date:3/6/2015)... CHESTNUT RIDGE, N.Y. , March 6, 2015 ... it will host a conference call on Friday, ... review its results of operations for the fourth ... Par is privately held and currently makes certain ... filings with the Securities and Exchange Commission and ...
(Date:3/6/2015)... Del. , March 6, 2015 ... and Trademark Office,s publication of U.S. Patent Application ... Disorder."  The ,249 Patent Application features claimed methods of ... be used to treat Binge Eating Disorder (,BED,)," ... material," or "flyer or an advertisement," as well ...
(Date:3/5/2015)... 2015 BioLineRx (NASDAQ: BLRX ... to identifying, in-licensing and developing promising therapeutic candidates, ... public offering of American Depositary Shares ("ADSs"), each ... of the ADSs in the offering are to ... Securities is acting as sole book-running manager for ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3
... Mich., June 15, 2011 Perrigo Company (Nasdaq: ... Industries Ltd. (Nasdaq: TEVA ) (previously Barr Laboratories ... Teva was the first applicant to file a complete ANDA ... be launching the product with 180 days of generic exclusivity. ...
... BRANFORD, Connecticut, June 15, 2011 , ... has killed dozens and,hospitalized thousands across Europe has been ... to generate the,"most accurate and detailed genetic analysis to ... ] ,The sequencing was performed by scientists at the ...
Cached Medicine Technology:Perrigo Announces Launch of the Generic Version of Nasacort® AQ 2Perrigo Announces Launch of the Generic Version of Nasacort® AQ 3Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 2Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: